C3is (CISS) Competitors

$3.21 +0.02 (+0.63%)

As of 02:12 PM Eastern

CISS vs. SGLY, SQZ, USDP, AIRTP, and RA

Should you buy C3is stock or one of its competitors? MarketBeat compares C3is with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with C3is include Singularity Future Technology (SGLY), SQZ Biotechnologies (SQZ), USD Partners (USDP), Air T (AIRTP), and Brookfield Real Assets Income Fund (RA). These companies are all part of the "transportation" industry.

How does C3is compare to Singularity Future Technology?

C3is (NASDAQ:CISS) and Singularity Future Technology (NASDAQ:SGLY) are both small-cap transportation companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

In the previous week, Singularity Future Technology had 1 more articles in the media than C3is. MarketBeat recorded 4 mentions for Singularity Future Technology and 3 mentions for C3is. C3is' average media sentiment score of 0.29 beat Singularity Future Technology's score of -0.53 indicating that C3is is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
C3is	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Singularity Future Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Singularity Future Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

10.5% of C3is shares are held by institutional investors. Comparatively, 4.1% of Singularity Future Technology shares are held by institutional investors. 10.2% of Singularity Future Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

C3is has higher revenue and earnings than Singularity Future Technology. Singularity Future Technology is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
C3is	$34.76M	0.01	$10.47M	-$1.13 thousand	N/A
Singularity Future Technology	$1.81M	0.98	-$3.91M	-$3.06	N/A

C3is has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, Singularity Future Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market.

C3is has a net margin of 30.13% compared to Singularity Future Technology's net margin of -987.08%. C3is' return on equity of 2.38% beat Singularity Future Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
C3is	30.13%	2.38%	2.04%
Singularity Future Technology	-987.08%	-56.78%	-20.64%

Summary

C3is beats Singularity Future Technology on 8 of the 13 factors compared between the two stocks.

How does C3is compare to SQZ Biotechnologies?

C3is (NASDAQ:CISS) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

C3is has a net margin of 30.13% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 2.38% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
C3is	30.13%	2.38%	2.04%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

In the previous week, C3is had 3 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 3 mentions for C3is and 0 mentions for SQZ Biotechnologies. C3is' average media sentiment score of 0.29 beat SQZ Biotechnologies' score of 0.00 indicating that C3is is being referred to more favorably in the media.

Company	Overall Sentiment
C3is	Neutral
SQZ Biotechnologies	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

C3is has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, SQZ Biotechnologies has a beta of 2.34, suggesting that its share price is 134% more volatile than the broader market.

C3is has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
C3is	$34.76M	0.01	$10.47M	-$1.13 thousand	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

10.5% of C3is shares are owned by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

C3is beats SQZ Biotechnologies on 9 of the 14 factors compared between the two stocks.

How does C3is compare to USD Partners?

USD Partners (NYSE:USDP) and C3is (NASDAQ:CISS) are both small-cap transportation companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

C3is has a net margin of 30.13% compared to USD Partners' net margin of -94.39%. C3is' return on equity of 2.38% beat USD Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USD Partners	-94.39%	N/A	-28.33%
C3is	30.13%	2.38%	2.04%

In the previous week, C3is had 3 more articles in the media than USD Partners. MarketBeat recorded 3 mentions for C3is and 0 mentions for USD Partners. C3is' average media sentiment score of 0.29 beat USD Partners' score of 0.00 indicating that C3is is being referred to more favorably in the news media.

Company	Overall Sentiment
USD Partners	Neutral
C3is	Neutral

0.1% of USD Partners shares are owned by institutional investors. Comparatively, 10.5% of C3is shares are owned by institutional investors. 2.6% of USD Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

USD Partners has higher revenue and earnings than C3is. C3is is trading at a lower price-to-earnings ratio than USD Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USD Partners	$72.32M	0.00	$17.77M	-$1.06	N/A
C3is	$34.76M	0.01	$10.47M	-$1.13 thousand	N/A

USD Partners has a beta of -0.18, suggesting that its stock price is 118% less volatile than the broader market. Comparatively, C3is has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USD Partners	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

C3is beats USD Partners on 9 of the 14 factors compared between the two stocks.

How does C3is compare to Air T?

Air T (NASDAQ:AIRTP) and C3is (NASDAQ:CISS) are both transportation companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Air T	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

C3is has a net margin of 30.13% compared to Air T's net margin of 0.00%. C3is' return on equity of 2.38% beat Air T's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Air T	N/A	N/A	N/A
C3is	30.13%	2.38%	2.04%

In the previous week, C3is had 1 more articles in the media than Air T. MarketBeat recorded 3 mentions for C3is and 2 mentions for Air T. Air T's average media sentiment score of 0.31 beat C3is' score of 0.29 indicating that Air T is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Air T	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
C3is	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

C3is has lower revenue, but higher earnings than Air T.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Air T	$272.47M	N/A	N/A	N/A	N/A
C3is	$34.76M	0.01	$10.47M	-$1.13 thousand	N/A

10.5% of C3is shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

C3is beats Air T on 6 of the 8 factors compared between the two stocks.

How does C3is compare to Brookfield Real Assets Income Fund?

C3is (NASDAQ:CISS) and Brookfield Real Assets Income Fund (NYSE:RA) are both transportation companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

C3is has a net margin of 30.13% compared to Brookfield Real Assets Income Fund's net margin of 0.00%. C3is' return on equity of 2.38% beat Brookfield Real Assets Income Fund's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
C3is	30.13%	2.38%	2.04%
Brookfield Real Assets Income Fund	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Brookfield Real Assets Income Fund	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

10.5% of C3is shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

C3is has higher earnings, but lower revenue than Brookfield Real Assets Income Fund. Brookfield Real Assets Income Fund is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
C3is	$34.76M	0.01	$10.47M	-$1.13 thousand	N/A
Brookfield Real Assets Income Fund	$64.90M	N/A	N/A	-$0.11	N/A

In the previous week, C3is had 1 more articles in the media than Brookfield Real Assets Income Fund. MarketBeat recorded 3 mentions for C3is and 2 mentions for Brookfield Real Assets Income Fund. C3is' average media sentiment score of 0.29 beat Brookfield Real Assets Income Fund's score of -1.00 indicating that C3is is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
C3is	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Brookfield Real Assets Income Fund	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

C3is beats Brookfield Real Assets Income Fund on 8 of the 10 factors compared between the two stocks.

Get C3is News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CISS vs. The Competition

Export

Metric	C3is	TRANS Industry	Transportation Sector	NASDAQ Exchange
Market Cap	$482K	$3.20B	$8.16B	$12.35B
Dividend Yield	N/A	5.51%	965.03%	5.35%
P/E Ratio	0.00	16.44	22.81	25.39
Price / Sales	0.01	5.30	4.40	73.15
Price / Cash	0.06	6.73	8.08	56.33
Price / Book	0.00	1.24	2.12	6.93
Net Income	$10.47M	$291.51M	$533.83M	$333.88M
7 Day Performance	-2.43%	-2.35%	-3.12%	0.03%
1 Month Performance	-45.65%	3.82%	-0.38%	1.93%
1 Year Performance	-99.39%	56.49%	33.90%	33.14%

C3is Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CISS C3is	0.279 of 5 stars	$3.21 +0.6%	N/A	-99.4%	$482K	$34.76M	N/A	N/A	News Coverage Upcoming Earnings Short Interest Increase
SGLY Singularity Future Technology	0.3038 of 5 stars	$0.44 -0.8%	N/A	-53.2%	$1.84M	$1.29M	N/A	40	Short Interest Increase Gap Down
SQZ SQZ Biotechnologies	N/A	$0.02 flat	N/A	N/A	$708K	$18.16M	N/A	1,620
USDP USD Partners	N/A	$0.00 +35.0%	N/A	-78.0%	$91K	$72.32M	N/A	90	High Trading Volume
AIRTP Air T	N/A	$20.42 +0.3%	N/A	+14.3%	$0.00	$272.47M	N/A	500	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CISS) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

C3is (CISS) Competitors

CISS vs. SGLY, SQZ, USDP, AIRTP, and RA

How does C3is compare to Singularity Future Technology?

Summary

How does C3is compare to SQZ Biotechnologies?

Summary

How does C3is compare to USD Partners?

Summary

How does C3is compare to Air T?

Summary

How does C3is compare to Brookfield Real Assets Income Fund?

Summary

Media Sentiment Over Time

CISS vs. The Competition

C3is Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

C3is (CISS) Competitors

CISS vs. SGLY, SQZ, USDP, AIRTP, and RA

How does C3is compare to Singularity Future Technology?

Does the media favor CISS or SGLY?

Do analysts prefer CISS or SGLY?

Do insiders & institutionals have more ownership in CISS or SGLY?

Which has higher earnings and valuation, CISS or SGLY?

Which has more risk & volatility, CISS or SGLY?

Is CISS or SGLY more profitable?

Summary

How does C3is compare to SQZ Biotechnologies?

Is CISS or SQZ more profitable?

Does the media prefer CISS or SQZ?

Do analysts recommend CISS or SQZ?

Which has more risk and volatility, CISS or SQZ?

Which has better valuation and earnings, CISS or SQZ?

Do institutionals and insiders have more ownership in CISS or SQZ?

Summary

How does C3is compare to USD Partners?

Is USDP or CISS more profitable?

Does the media refer more to USDP or CISS?

Do insiders and institutionals hold more shares of USDP or CISS?

Which has better earnings & valuation, USDP or CISS?

Which has more risk & volatility, USDP or CISS?

Do analysts recommend USDP or CISS?

Summary

How does C3is compare to Air T?

Do analysts recommend AIRTP or CISS?

Is AIRTP or CISS more profitable?

Does the media refer more to AIRTP or CISS?

Which has better earnings & valuation, AIRTP or CISS?

Do insiders and institutionals hold more shares of AIRTP or CISS?

Summary

How does C3is compare to Brookfield Real Assets Income Fund?

Is CISS or RA more profitable?

Do analysts recommend CISS or RA?

Do institutionals and insiders hold more shares of CISS or RA?

Which has preferable valuation and earnings, CISS or RA?

Does the media favor CISS or RA?

Summary

Media Sentiment Over Time

CISS vs. The Competition

C3is Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools